FOIDART; Jean-Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for FOIDART; Jean-Michel.The latest application filed is for "contraceptive compositions with reduced adverse effects".

Company Profile

0.8.20

FOIDART; Jean-Michel - Liege BE
Foidart; Jean-Michel - For t Trooz BE
Foidart; Jean-Michel - Trooz BE
Foidart; Jean-Michel - Foret Trooz BE
Foidart; Jean-Michel - Forest-Trooz BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Contraceptive Compositions With Reduced Adverse Effects App 20220211722 - FOIDART; Jean-Michel	2022-07-07
Use Of Estetrol As Emergency Contraceptive App 20210290636 - Wouters; Wout ; et al.	2021-09-23
Eye device Grant 9,999,595 - Rakic , et al. June 19, 2	2018-06-19
Estrogenic components for use in the treatment of neurological disorders Grant 9,808,470 - Foidart , et al. November 7, 2	2017-11-07
Use Of Estetrol As Emergency Contraceptive App 20170196886 - Wouters; Wout ; et al.	2017-07-13
Use of estetrol as emergency contraceptive Grant 9,579,329 - Wouters , et al. February 28, 2	2017-02-28
Eye Device App 20160287513 - Rakic; Jean-Marie ; et al.	2016-10-06
Estrogenic Components For Use In The Treatment Of Neurological Disorders App 20160101116 - FOIDART; Jean-Michel ; et al.	2016-04-14
Estrogenic components for use in the treatment of neurological disorders Grant 9,238,035 - Foidart , et al. January 19, 2	2016-01-19
Estrogenic Components For Use In The Treatment Of Neurological Disorders App 20150133419 - Foidart; Jean-Michel ; et al.	2015-05-14
Use Of Estetrol As Emergency Contraceptive App 20140200202 - Wouters; Wout ; et al.	2014-07-17
Implant Having A Core And A Tube Encasing The Core App 20130297040 - Donnez; Jacques ; et al.	2013-11-07
Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases App 20120295872 - Cataldo; Didier ; et al.	2012-11-22
Pharmaceutical compositions of pyrimidine-2,4,6-triones Grant 8,044,035 - Bartsch , et al. October 25, 2	2011-10-25
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis Grant 8,034,828 - Badorc , et al. October 11, 2	2011-10-11
Use Of Cyclodextrin For Treatment And Prevention Of Bronchial Inflammatory Diseases App 20110028432 - Cataldo; Didier ; et al.	2011-02-03
Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases Grant 7,829,550 - Cataldo , et al. November 9, 2	2010-11-09
Pharmaceutical Compositions Of Pyrimidine-2,4,6-triones App 20100261672 - Bartsch; Pierre ; et al.	2010-10-14
Use Of Fgf Inhibiting Substituted 1,2,3 Indolizine Derivatives In The Preparation Of Medicaments Which Can Be Used To Treat Diseases Linked To Pathological Choroidal Angiogenesis App 20090030034 - BADORC; Alain ; et al.	2009-01-29
Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases App 20090012041 - Cataldo; Didier ; et al.	2009-01-08
Mucoadhesive Pharmaceutical Compositions Comprising Chemoattractants App 20080293630 - Herman; Ludivine ; et al.	2008-11-27
Active Substance Delivery System Comprising A Hydrogel Atrix And Microcarriers App 20080095822 - MAQUET; Veronique ; et al.	2008-04-24
5-(1,1'Biphenyl)-4-Yl-5-(4-(4-Aminoacylphenyl)-Piperazin)-1-Yl-Pyrimidine-- 2,4,6,-Trione Derivatives, As Inhibitors Of Zinc Metallondopeptidases, Their Preparation And Use App 20080096897 - Pirotte; Bernard ; et al.	2008-04-24
Pharmaceutical compositions of pyrimidine-2,4,6-triones App 20070191404 - Bartsch; Pierre ; et al.	2007-08-16
Mucoadhesive composition comprising polyacrylate and chemoattractant App 20060228417 - Hubert; Pascale ; et al.	2006-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.